上皮成長因子（EGF）のグローバル市場2021

• 英文タイトル：Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Report 2021

• レポートコード：QAF27671
• 出版社/出版日：QYResearch / 2021年4月13日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、131ページ
• 納品方法：Eメール（即日納品）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本市場調査資料では、世界の上皮成長因子（EGF）市場について種類別（液体、粉末）、用途別（EGFクリーム、EGFローション、EGFマスク、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・上皮成長因子（EGF）市場の概要
・世界の主要地域別上皮成長因子（EGF）市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の上皮成長因子（EGF）市場規模2016-2021：種類別（液体、粉末）
・世界の上皮成長因子（EGF）市場予測2012-2027：種類別（液体、粉末）
・世界の上皮成長因子（EGF）市場規模2016-2021：用途別（EGFクリーム、EGFローション、EGFマスク、その他）
・世界の上皮成長因子（EGF）市場予測2012-2027：用途別（EGFクリーム、EGFローション、EGFマスク、その他）
・上皮成長因子（EGF）のアメリカ市場規模と予測2016-2021
・上皮成長因子（EGF）のヨーロッパ市場規模と予測2016-2021
・上皮成長因子（EGF）の中国市場規模と予測2016-2021
・上皮成長因子（EGF）の日本市場規模と予測2016-2021
・上皮成長因子（EGF）の東南アジア市場規模と予測2016-2021
・上皮成長因子（EGF）のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報：事業概要・売上・企業動向
（Pavay、Radiant、BIO-FD&C、LipoTrue、BIOEFFECT）
・上皮成長因子（EGF）の製造コスト分析
・販売チャネル、流通業者、顧客
・上皮成長因子（EGF）の市場動向・機会・課題
・調査の結論

Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival.

EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that’s why most skin care maker use EGF to care our skin.

And we only investigate the epidermal growth factor (EGF) cosmetic, take no account of the epidermal growth factor (EGF) for research use.
The classification of Epidermal Growth Factor (EGF) includes liquid and powder. The proportion of liquid in 2016 is about 25%, the proportion of powder in 2016 is about 75%.

The application of Epidermal Growth Factor (EGF) is divided into EGF Cream, EGF Lotion, EGF Mask and others. The most of Epidermal Growth Factor (EGF) is EGF Cream, and the market share of that is about 45% in 2016.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 34% in 2016. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 25% in 2016. And South America in the third largest consumption region with the consumption market share of 10%.

Market competition is intense. Pavay, Radiant, BIO-FD&C, LipoTrue, BIOEFFECT are the leaders of the industry, with high-end customers in the industry.

Market Analysis and Insights: Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market
The global Epidermal Growth Factor (EGF) (CAS 62253-63-8) market was valued at US$ 135.6 in 2020 and will reach US$ 189.1 million by the end of 2027, growing at a CAGR of 5.7% during 2022-2027.

Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Scope and Market Size
The global Epidermal Growth Factor (EGF) (CAS 62253-63-8) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epidermal Growth Factor (EGF) (CAS 62253-63-8) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Liquid
Powder

Segment by Application
EGF Cream
EGF Lotion
EGF Mask
Other

The Epidermal Growth Factor (EGF) (CAS 62253-63-8) market is analysed and market size information is provided by regions (countries). Segment by Application, the Epidermal Growth Factor (EGF) (CAS 62253-63-8) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Pavay
Radiant
BIO-FD&C
LipoTrue
BIOEFFECT

レポート目次

1 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Overview
1.1 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Scope
1.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Segment by Type
1.2.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2016 & 2021 & 2027)
1.2.2 Liquid
1.2.3 Powder
1.3 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Segment by Application
1.3.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 EGF Cream
1.3.3 EGF Lotion
1.3.4 EGF Mask
1.3.5 Other
1.4 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price Trends (2016-2027)

2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Estimates and Forecasts by Region
2.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Region (2016-2021)
2.2.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Region (2016-2021)
2.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Estimates and Projections (2016-2027)
2.4.2 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Estimates and Projections (2016-2027)
2.4.3 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Estimates and Projections (2016-2027)
2.4.4 Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Estimates and Projections (2016-2027)
2.4.6 India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Estimates and Projections (2016-2027)
3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Competition Landscape by Players
3.1 Global Top Epidermal Growth Factor (EGF) (CAS 62253-63-8) Players by Sales (2016-2021)
3.2 Global Top Epidermal Growth Factor (EGF) (CAS 62253-63-8) Players by Revenue (2016-2021)
3.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Epidermal Growth Factor (EGF) (CAS 62253-63-8) as of 2020)
3.4 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Average Price by Company (2016-2021)
3.5 Manufacturers Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size by Type
4.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Historic Market Review by Type (2016-2021)
4.1.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2016-2021)
4.1.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Type (2016-2021)
4.1.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price by Type (2016-2021)
4.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Forecast by Type (2022-2027)
4.2.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Forecast by Type (2022-2027)
4.2.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price Forecast by Type (2022-2027)
5 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size by Application
5.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Historic Market Review by Application (2016-2021)
5.1.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2016-2021)
5.1.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Application (2016-2021)
5.1.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price by Application (2016-2021)
5.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Forecast by Application (2022-2027)
5.2.2 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Forecast by Application (2022-2027)
5.2.3 Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price Forecast by Application (2022-2027)

6 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Facts & Figures
6.1 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company
6.1.1 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company (2016-2021)
6.1.2 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021)
6.2 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type
6.2.1 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2016-2021)
6.2.2 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2022-2027)
6.3 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Application
6.3.1 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Application (2016-2021)
6.3.2 North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Application (2022-2027)

7 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Facts & Figures
7.1 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company
7.1.1 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company (2016-2021)
7.1.2 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021)
7.2 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type
7.2.1 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2022-2027)
7.3 Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Application
7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)

8 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Facts & Figures
8.1 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company
8.1.1 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company (2016-2021)
8.1.2 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021)
8.2 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type
8.2.1 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2016-2021)
8.2.2 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2022-2027)
8.3 China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Facts & Figures
9.1 Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company
9.1.1 Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company (2016-2021)
9.1.2 Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021)
9.2 Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type
9.2.1 Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2022-2027)
9.3 Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Facts & Figures
10.1 Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company
10.1.1 Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company (2016-2021)
10.1.2 Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021)
10.2 Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type
10.2.1 Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Application
10.3.1 Southeast Asia g Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia g Sales Breakdown by Application (2022-2027)

11 India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Facts & Figures
11.1 India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company
11.1.1 India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Company (2016-2021)
11.1.2 India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021)
11.2 India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type
11.2.1 India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2016-2021)
11.2.2 India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Type (2022-2027)
11.3 India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Application
11.3.1 India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Application (2016-2021)
11.3.2 India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Epidermal Growth Factor (EGF) (CAS 62253-63-8) Business
12.1 Pavay
12.1.1 Pavay Corporation Information
12.1.2 Pavay Business Overview
12.1.3 Pavay Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pavay Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
12.1.5 Pavay Recent Development
12.2 Radiant
12.2.1 Radiant Corporation Information
12.2.2 Radiant Business Overview
12.2.3 Radiant Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Radiant Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
12.2.5 Radiant Recent Development
12.3 BIO-FD&C
12.3.1 BIO-FD&C Corporation Information
12.3.2 BIO-FD&C Business Overview
12.3.3 BIO-FD&C Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 BIO-FD&C Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
12.3.5 BIO-FD&C Recent Development
12.4 LipoTrue
12.4.1 LipoTrue Corporation Information
12.4.2 LipoTrue Business Overview
12.4.3 LipoTrue Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 LipoTrue Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
12.4.5 LipoTrue Recent Development
12.5 BIOEFFECT
12.5.1 BIOEFFECT Corporation Information
12.5.2 BIOEFFECT Business Overview
12.5.3 BIOEFFECT Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 BIOEFFECT Epidermal Growth Factor (EGF) (CAS 62253-63-8) Products Offered
12.5.5 BIOEFFECT Recent Development
…

13 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturing Cost Analysis
13.1 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Epidermal Growth Factor (EGF) (CAS 62253-63-8)
13.4 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Distributors List
14.3 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Customers

15 Market Dynamics
15.1 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Trends
15.2 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Drivers
15.3 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Challenges
15.4 Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Region (2016-2021)
Table 5. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Region (2016-2021)
Table 6. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Region (2016-2021)
Table 8. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) Forecast by Region (2022-2027)
Table 9. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) of Key Companies (2016-2021)
Table 13. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Company (2016-2021)
Table 14. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Company (2016-2021)
Table 16. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epidermal Growth Factor (EGF) (CAS 62253-63-8) as of 2020)
Table 17. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Average Price (USD/g) of Key Company (2016-2021)
Table 18. Manufacturers Epidermal Growth Factor (EGF) (CAS 62253-63-8) Manufacturing Sites and Area Served
Table 19. Manufacturers Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Type (2016-2021)
Table 22. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Type (2016-2021)
Table 23. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price (USD/g) by Type (2016-2021)
Table 25. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Type (2022-2027)
Table 26. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Type (2022-2027)
Table 28. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price (USD/g) by Type (2022-2027)
Table 29. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Application (2016-2021)
Table 30. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Application (2016-2021)
Table 31. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price (USD/g) by Application (2016-2021)
Table 33. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Application (2022-2027)
Table 34. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Share by Application (2022-2027)
Table 35. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Application (2022-2027)
Table 37. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price (USD/g) by Application (2022-2027)
Table 38. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Company (2016-2021)
Table 39. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Company (2016-2021)
Table 40. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Company (2016-2021)
Table 42. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2016-2021) & (g)
Table 43. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2016-2021)
Table 44. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2022-2027) & (g)
Table 45. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2022-2027)
Table 46. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2016-2021) & (g)
Table 47. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2016-2021)
Table 48. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2022-2027) & (g)
Table 49. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2022-2027)
Table 50. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Company (2016-2021)
Table 51. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Company (2016-2021)
Table 52. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Company (2016-2021)
Table 54. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2016-2021) & (g)
Table 55. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2016-2021)
Table 56. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2022-2027) & (g)
Table 57. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2022-2027)
Table 58. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2016-2021) & (g)
Table 59. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2016-2021)
Table 60. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2022-2027) & (g)
Table 61. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2022-2027)
Table 62. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Company (2016-2021)
Table 63. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Company (2016-2021)
Table 64. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Company (2016-2021)
Table 66. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2016-2021) & (g)
Table 67. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2016-2021)
Table 68. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2022-2027) & (g)
Table 69. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2022-2027)
Table 70. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2016-2021) & (g)
Table 71. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2016-2021)
Table 72. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2022-2027) & (g)
Table 73. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2022-2027)
Table 74. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Company (2016-2021)
Table 75. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Company (2016-2021)
Table 76. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Company (2016-2021)
Table 78. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2016-2021) & (g)
Table 79. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2016-2021)
Table 80. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2022-2027) & (g)
Table 81. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2022-2027)
Table 82. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2016-2021) & (g)
Table 83. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2016-2021)
Table 84. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2022-2027) & (g)
Table 85. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Company (2016-2021)
Table 87. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2016-2021) & (g)
Table 91. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2022-2027) & (g)
Table 93. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2016-2021) & (g)
Table 95. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2022-2027) & (g)
Table 97. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2022-2027)
Table 98. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) by Company (2016-2021)
Table 99. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Company (2016-2021)
Table 100. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Company (2016-2021)
Table 102. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2016-2021) & (g)
Table 103. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2016-2021)
Table 104. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Type (2022-2027) & (g)
Table 105. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type (2022-2027)
Table 106. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2016-2021) & (g)
Table 107. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2016-2021)
Table 108. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales by Application (2022-2027) & (g)
Table 109. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application (2022-2027)
Table 110. Pavay Corporation Information
Table 111. Pavay Description and Business Overview
Table 112. Pavay Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 113. Pavay Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product
Table 114. Pavay Recent Development
Table 115. Radiant Corporation Information
Table 116. Radiant Description and Business Overview
Table 117. Radiant Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 118. Radiant Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product
Table 119. Radiant Recent Development
Table 120. BIO-FD&C Corporation Information
Table 121. BIO-FD&C Description and Business Overview
Table 122. BIO-FD&C Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 123. BIO-FD&C Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product
Table 124. BIO-FD&C Recent Development
Table 125. LipoTrue Corporation Information
Table 126. LipoTrue Description and Business Overview
Table 127. LipoTrue Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 128. LipoTrue Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product
Table 129. LipoTrue Recent Development
Table 130. BIOEFFECT Corporation Information
Table 131. BIOEFFECT Description and Business Overview
Table 132. BIOEFFECT Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g), Revenue (Million USD), Price (USD/g) and Gross Margin (2016-2021)
Table 133. BIOEFFECT Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product
Table 134. BIOEFFECT Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Distributors List
Table 138. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Customers List
Table 139. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Trends
Table 140. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Drivers
Table 141. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Challenges
Table 142. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Product Picture
Figure 2. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application in 2021 & 2027
Figure 6. EGF Cream Examples
Figure 7. EGF Lotion Examples
Figure 8. EGF Mask Examples
Figure 9. Other Examples
Figure 10. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) Growth Rate (2016-2027)
Figure 13. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Price Trends Growth Rate (2016-2027) (USD/g)
Figure 14. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (g) Growth Rate (2016-2027)
Figure 18. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Epidermal Growth Factor (EGF) (CAS 62253-63-8) Players Market Share by Revenue in Epidermal Growth Factor (EGF) (CAS 62253-63-8): 2016 & 2020
Figure 29. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Type (2016-2021)
Figure 31. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Share by Application (2016-2021)
Figure 33. Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type in 2020
Figure 35. North America Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application in 2020
Figure 36. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type in 2020
Figure 37. Europe Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application in 2020
Figure 38. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type in 2020
Figure 39. China Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application in 2020
Figure 40. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type in 2020
Figure 41. Japan Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application in 2020
Figure 42. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type in 2020
Figure 43. Southeast Asia Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application in 2020
Figure 44. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Type in 2020
Figure 45. India Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Epidermal Growth Factor (EGF) (CAS 62253-63-8)
Figure 48. Manufacturing Process Analysis of Epidermal Growth Factor (EGF) (CAS 62253-63-8)
Figure 49. Epidermal Growth Factor (EGF) (CAS 62253-63-8) Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2021-2027
QFJ1-5726 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、上皮成長因子受容体（EGFR）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、大腸がん、乳がん、その他）、用途別市場規模（病院、研究所、研究機関、診療所、その他）、主要地域別市場規模（北...

世界のHER2 (ヒト上皮成長因子受容体 2) 阻害剤市場規模・現状・予測（2021年-2027年）

Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-4306 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、HER2 (ヒト上皮成長因子受容体 2) 阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（乳がん、胃がん、卵巣がん、その他）、主要地域別市場規模（北米、アメ...

ヒト血液凝固因子VIIのグローバル市場2021

Global Human Coagulation Factor VII Sales Market Report 2021
QAF27718 2021年4月5日 133Pages
本市場調査資料では、世界のヒト血液凝固因子VII市場について種類別（遺伝子組換え型第VIII因子、血漿由来第VIII因子）、用途別（血友病A、自然発症/外傷、外科、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規...

世界のグリア細胞株由来神経栄養因子市場規模・現状・予測（2021年-2027年）

Global Glial Cell Line Derived Neurotrophic Factor Market Size, Status and Forecast 2021-2027
QFJ1-5755 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、グリア細胞株由来神経栄養因子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（GSK-812、LAUR-301、TW-002、AMT-090、その他）、用途別市場規模（筋萎縮性側索硬化症、脳虚血、パーキ...

世界のトランスフォーミング増殖因子ベータ 2市場規模・現状・予測（2021年-2027年）

Global Transforming Growth Factor Beta 2 Market Size, Status and Forecast 2021-2027
QFJ1-6050 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、トランスフォーミング増殖因子ベータ 2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（XOMA-089、トラベダーセン、ISTH-0047、その他）、用途別市場規模（多形性膠芽腫、開放隅角緑内障、肝線...

世界の凝固第XI因子市場規模・現状・予測（2021年-2027年）

Global Coagulation Factor XI Market Size, Status and Forecast 2021-2027
QFJ1-5665 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、凝固第XI因子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MR-1007、IONIS-FXIRx、EP-7041、AB-022、BMS-262084、その他）、用途別市場規模（血栓症、出血＆凝固障...

世界のNT3成長因子受容体市場規模・現状・予測（2021年-2027年）

Global NT 3 Growth Factor Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5898 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、NT3成長因子受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AZD-7451、ラロトレクチニブ、DS-6051、LM-22B10、その他）、用途別市場規模（乳がん、脳がん、固形がん、結腸がん、...

世界の血管内皮増殖因子（VEGF）阻害剤市場規模・現状・予測（2021年-2027年）

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-6061 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、血管内皮増殖因子（VEGF）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）、用途別市場規模（腫瘍、眼科）、主要地...

世界の腫瘍壊死因子（TNF）阻害薬市場規模・現状・予測（2021年-2027年）

Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6054 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腫瘍壊死因子（TNF）阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Humira、Enbrel、Remicade、Simponi/Simponi Aria、Cimzia、バイオシミラー）、用途...

ヒト血液凝固因子VIIIのグローバル市場2021

Global Human Coagulation Factor VIII Sales Market Report 2021
QAF27719 2021年4月8日 147Pages
本市場調査資料では、世界のヒト血液凝固因子VIII市場について種類別（遺伝子組換え型第VIII因子、血漿由来第VIII因子）、用途別（血友病A、自然発症/外傷、外科、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場...

世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年） The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands. The high efficacy of EGFR inhibitors in the treatment of various types of cancer indicati…
世界のHER2 (ヒト上皮成長因子受容体 2) 阻害剤市場規模・現状・予測（2021年-2027年） HER2 regulates cell growth, survival and differentiation through a variety of signal transduction pathways.Several cancers, including breast, stomach and ovarian, are on the rise because of overexpression of HER2, which is inhibited by HER2 inhibitors Market Analysis and Insights: Global HER2 (Human…
ヒト血液凝固因子VIIのグローバル市場2021 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…
世界のトランスフォーミング増殖因子ベータ 2市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Transforming Growth Factor Beta 2 Market The global Transforming Growth Factor Beta 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…
世界のグリア細胞株由来神経栄養因子市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glial Cell Line Derived Neurotrophic Factor Market The global Glial Cell Line Derived Neurotrophic Factor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …